ProfileGDS5678 / 1421568_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 14% 12% 12% 12% 12% 12% 12% 12% 12% 12% 12% 12% 12% 12% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.3634314
GSM967853U87-EV human glioblastoma xenograft - Control 22.2977212
GSM967854U87-EV human glioblastoma xenograft - Control 32.2973512
GSM967855U87-EV human glioblastoma xenograft - Control 42.2483212
GSM967856U87-EV human glioblastoma xenograft - Control 52.2435412
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.35512
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.3158912
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.277912
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.2674612
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.286212
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.2858212
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.2707112
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.2938812
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.2892212